In a report released today, Cory Kasimov from J.P. Morgan maintained a Buy rating on Incyte Corp (INCY). The company’s shares opened today at $74.61. According to TipRanks.com, Kasimov is a 2-star analyst with an average return of 0.3% and a 40.5% success rate. Kasimov covers the Healthcare sector, focusing on stocks such as Ultragenyx […]

Rupal J. Bhansali provides a framework and best practices for non-consensus investing.

I arrived back home to Puerto Rico late last night after traveling back from our Total Access event in Las Vegas. It was probably around 11:15 pm when I climbed into bed. And, within minutes, just as the sound of the waves outside was carrying me off to sleep, the whole house started violently shaking. […]